Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
PerkinElmer Signals software platform supports aggregation, curation, and searching of data from desperate ...
L'augmentation des coûts liés au développement de médicaments constitue une motivation importante en faveur ...
The increasing costs associated with drug development present a strong case for the use of translational ...
Advances in genetic sequencing, biotechnology, systems biology, and molecular imaging are completely changing ...
Presenter: Rebecca Laborde, PhD.
Field Application Scientist, Regional Marketing ...
The cost of drug production has soared into the billions, presenting a huge barrier to companies hoping to market new medicines and creating a pressing need for more efficient development techniques.
Translational Medicine Informatics requires managing clinical, biobank, and research data in an integrated ...
Translational Medicine is developing into a key enabling suite of data-rich technologies that is transforming ...
Originally presented at Bio-IT World April 10, 2013